A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP

This study aimed to compare the efficacy and safety of rituximab (RTX) plus recombinant human thrombopoietin (rhTPO) with RTX alone in patients with immune thrombocytopenia (ITP) who had failed to respond to corticosteroids or relapsed. Recruited patients were randomized at a ratio of 2:1 into 2 gro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood
Hauptverfasser: Zhou, Hai, Xu, Miao, Qin, Ping, Zhang, Hai-yan, Yuan, Cheng-lu, Zhao, Hong-guo, Cui, Zhong-guang, Meng, Yue-sheng, Wang, Lei, Zhou, Fang, Wang, Xin, Li, Da-qi, Bi, Ke-hong, Zhu, Chuan-sheng, Guo, Cheng-shan, Chu, Xiao-xia, Wu, Qing-chao, Liu, Xin-guang, Dong, Xiao-yuan, Li, Jie, Peng, Jun, Hou, Ming
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2015
Schlagworte:
Clinical Trials and Observations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351949/
https://ncbi.nlm.nih.gov/pubmed/25575541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-581868
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge